PAVmed Inc.

In over three decades in medicine, Lishan Aklog has experienced breakthrough moments as a heart surgeon in the US, UK and France, and since 2018, as chair and CEO of Lucid Diagnostics, Inc. , which is

PAVmed Inc. subsidiary Lucid Diagnostics will become a separate public company focused on commercializing EsoGuard, a DNA-based test for detecting precursors to esophageal cancer, and other products

[ Editors Note: Starts & Stops is Medtech Insight’ s regular review of important medical device trial announcements as tracked by Informa’s MedDeviceTracker . Click here to request a demonstra

US FDA has asked for additional information on a device to treat carpal tunnel syndrome after concluding it couldn’t be approved via the 510(k) pathway. The device, CarpX , would allow surgeons to tr